BillionToOne Secures $130 Million to Advance Pioneering Molecular Diagnostics, Achieves $1 Billion Valuation Milestone
BillionToOne, a trailblazing molecular diagnostics company, has achieved a significant milestone by raising $130 million in its Series D funding round, marking a valuation surpassing $1 billion. This oversubscribed financing round was led by Premji Invest, with major contributions from Neuberger Berman and existing investors Adam Street Partners, Baillie Gifford, and Hummingbird Ventures, among others….